Table 23.
Sixteen-Year Total Deaths and Median Survival in Months with 95% Confidence Intervals for Selected Primary Malignant Brain and Other Central Nervous System Tumor Histopathologies, CBTRUS Statistical Report: NPCR, 2001-201877
| Histopathology | N | Deaths | Median Survival (95% CI) |
|---|---|---|---|
| Diffuse astrocytoma | 25,047 | 13,802 | 61 (58-63) |
| Anaplastic astrocytoma | 17,821 | 12,453 | 20 (20-21) |
| Glioblastoma | 145,178 | 129,570 | 8 (8-8) |
| Oligodendroglioma | 11,989 | 3,722 | 199 (190-209) |
| Anaplastic oligodendroglioma | 5,351 | 2,532 | 103 (96-110) |
| Oligoastrocytic tumors | 6,941 | 3,503 | 113 (107-120) |
| Pilocytic astrocytoma | 15,813 | 1,197 | ** (**-**) |
| Unique astrocytoma variants | 2,463 | 420 | ** (**-**) |
| Ependymal tumors | 18,710 | 3,277 | ** (**-**) |
| Glioma malignant, NOS | 20,825 | 9,875 | 96 (87-106) |
| Other neuroepithelial tumors | 2,274 | 338 | ** (**-**) |
| Neuronal and mixed neuronal-glial tumors | 283 | 83 | ** (201-**) |
| Choroid plexus tumors | 12,602 | 1,559 | ** (**-**) |
| Tumors of the pineal region | 1,979 | 506 | ** (**-**) |
| Embryonal tumors | 10,715 | 4,194 | ** (**-**) |
| Nerve sheath tumors | 87,503 | 8,450 | ** (**-**) |
| Other tumors of cranial and spinal nerves | -- | -- | -- |
| Meningiomas | 382,599 | 107,072 | 185 (180-188) |
| Mesenchymal tumors | 16,764 | 2,943 | ** (**-**) |
| Primary melanocytic lesions | 281 | 174 | 28 (21-47) |
| Lymphoma | 19,855 | 13,519 | 16 (15-17) |
| Other hematopoietic neoplasms | 209 | 97 | 138 (98-**) |
| Germ cell tumors | 3,569 | 518 | ** (**-**) |
| Tumors of the pituitary | 172,615 | 20,558 | ** (**-**) |
| Craniopharyngioma | 8,005 | 1,673 | ** (**-**) |
| Hemangioma | 8,709 | 957 | ** (**-**) |
| Neoplasm, unspecified | 28,825 | 15,949 | 44 (41-48) |
| All other | 1,260 | 206 | ** (**-**) |
** Cannot be calculated due to median survival not being observed.-- Survival estimates are not presented when fewer than 100 cases were reported for the specific category.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; CI, confidence interval; NOS, not otherwise specified; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program.